Decreased core-fucosylation contributes to malignancy in gastric cancer

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Zhao, Yun Peng ^a   Xu, Xin Yun ^b   Fang, Meng ^a   Wang, Hao ^b   You, Qing ^b   Yi, Chang Hong ^a   Ji, Jun ^a   Gu, Xing ^a   Zhou, Ping Ting ^a   Cheng, Cheng ^a   Gao, Chun Fang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; BINDING PROTEIN; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHOLECYSTOKININ OCTAPEPTIDE; DNA; FUCOSYLTRANSFERASE; LECTIN; RNA; TUMOR MARKER; ALPHA LEVO FUCOSIDASE; FUCOSE; GLYCOPROTEIN 6-ALPHA-L-FUCOSYLTRANSFERASE; N ACETYLNEURAMINIC ACID; POLYSACCHARIDE;

ADULT; ARTICLE; CANCER CELL; CAPILLARY ELECTROPHORESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; FEMALE; FUCOSYLATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LENTIL; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STOMACH; STOMACH CANCER; STOMACH ULCER; UPREGULATION; WESTERN BLOTTING; BLOOD; CASE CONTROL STUDY; CELL MOTION; CHEMISTRY; DEMOGRAPHY; DISEASE COURSE; ENZYMOLOGY; GLYCOBIOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; WOUND HEALING;

ALPHA-L-FUCOSIDASE; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DEMOGRAPHY; DISEASE PROGRESSION; FEMALE; FUCOSE; FUCOSYLTRANSFERASES; GLYCOMICS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; POLYSACCHARIDES; STOMACH NEOPLASMS; STOMACH ULCER; WOUND HEALING;

EID: 84899648864     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094536     Document Type: Article

References (39)

1. Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, et al. (2013) Gastric Cancer, Version 2. J Natl Compr Canc Netw 11:531-546.
2. Brenner H, Rothenbacher D, Arndt V (2009) Epidemiology of stomach cancer. Methods Mol Biol 472:467-477.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917.
4. Yang L (2006) Incidence and mortality of gastric cancer in China. World J Gastroenterol 12:17-20. (Pubitemid 43126077)
5. Terman JR, Kashina A (2013) Post-translational modification and regulation of actin. Curr Opin Cell Biol 25:30-38.
6. Varki A (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3:97-130. (Pubitemid 23132602)
7. Tian Y, Zhang H (2010) Glycoproteomics and clinical applications. Proteomics Clin Appl 4:124-132.
8. Dai Z, Zhou J, Qiu SJ, Liu YK, Fan J (2009) Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers. Electrophoresis 30:2957-2966.
9. Li QK, Gabrielson E, Zhang H (2012) Application of glycoproteomics for the discovery of biomarkers in lung cancer. Proteomics Clin Appl 6:244-256.
10. Margineanu E, Cotrutz CE, Cotrutz C (2008) Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis. Rev Med Chir Soc Med Nat Iasi 112:432-436.
11. Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, et al. (2004) Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med 10:429-434. (Pubitemid 38508524)
12. Comunale MA, Lowman M, Long RE, Krakover J, Philip R, et al. (2006) Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J Proteome Res 5:308-315. (Pubitemid 43224256)
13. Muinelo-Romay L, Vázquez-Mart́n C, Villar-Portela S, Cuevas E, Gil-Mart́n E, et al. (2008) Expression and enzyme activity of alpha(1,6) fucosyltransferase in human colorectal cancer. Int J Cancer 123:641-646. (Pubitemid 351898423)
14. Chen CY, Jan YH, Juan YH, Yang CJ, Huang MS, et al. (2013) Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer. Proc Natl Acad Sci U S A 110:630-635.
15. Takahashi T, Ikeda Y, Miyoshi E, Yaginuma Y, Ishikawa M, et al. (2000) alpha1,6 fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas. Int J Cancer 88:914-919.
16. Longmore GD, Schachter H (1982) Product-identification and substratespecificity studies of the GDP-L-fucose:2-acetamido-2-deoxy-beta-D- glucoside (FUC goes to Asn-linked GlcNAc) 6-alpha-L-fucosyltransferase in a Golgi-rich fraction from porcine liver. Carbohydr Res 100:365-392.
17. Noda K, Miyoshi E, Gu J, Gao CX, Nakahara S, et al. (2003) Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines. Cancer Res 63:6282-6289. (Pubitemid 37255175)
18. Javaud C, Dupuy F, Maftah A, Julien R, Petit JM (2003) The fucosyltransferase gene family: an amazing summary of the underlying mechanisms of gene evolution. Genetica 118:157-170. (Pubitemid 36821046)
19. Fang M, Zhao YP, Zhou FG, Lu LG, Qi P, et al. (2010) N-glycan based models improve diagnostic efficacies in HBV-related hepatocellular carcinoma. Int J Cancer 127:148-159.
20. Zhao YP, Ruan CP, Wang H, Hu ZQ, Fang M, et al. (2012) Identification and assessment of new biomarkers for colorectal cancer with serum N-glycan profiling. Cancer 118:639-650.
21. Lebrilla CB, An HJ (2009) The prospects of glycan biomarkers for the diagnosis of diseases. Mol Biosyst 5:17-20.
22. Packer NH, von der Lieth CW, Aoki-Kinoshita KF, Lebrilla CB, Paulson JC, et al. (2008) Frontiers in glycomics: bioinformatics and biomarkers in disease. An NIH white paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11-13, 2006). Proteomics 8:8-20.
23. Ohtsubo K, Marth JD (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126:855-867. (Pubitemid 44310784)
24. Kobata A, Amano J (2005) Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumors. Immunol Cell Biol 83:429-439. (Pubitemid 41044621)
25. Moriwaki K, Miyoshi E (2010) Fucosylation and gastrointestinal cancer. World J Hepatol 2:151-161.
26. Zimmermann W, Friedrich R, Grunert F, Luckenbach GA, Thompson J, et al. (1983) Characterization of messenger RNA specific for carcinoembryonic antigen. Ann N Y Acad Sci 417:21-30. (Pubitemid 14187622)
27. Arnold JN, Saldova R, Hamid UM, Rudd PM (2008) Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 8:3284-3293.
28. Kam RK, Poon TC, Chan HL, Wong N, Hui AY, et al. (2007) High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis. Clin Chem 53:1254-1263. (Pubitemid 47020981)
29. Miyoshi E, Moriwaki K, Nakagawa T (2008) Biological function of fucosylation in cancer biology. J Biochem 143:725-729. (Pubitemid 351918934)
30. Saldova R, Dempsey E, Pérez-Garay M, Mariño K, Watson JA, et al. (2011) 5-AZA-29-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer. Epigenetics 6:1362-72.
31. Saldova R, Fan Y, Fitzpatrick JM, Watson RW, Rudd PM (2011) Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. Glycobiology. 21:195-205.
32. Barrabés S, Pagès-Pons L, Radcliffe CM, Tabarés G, Fort E (2007) Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. Glycobiology. 17:388-400. (Pubitemid 46432010)
33. Wang X, Gu J, Ihara H, Miyoshi E, Honke K, et al. (2006) Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling. J Biol Chem 281:2572-2577. (Pubitemid 43845717)
34. Biskup K, Braicu EI, Sehouli J, Fotopoulou C, Tauber R, Berger M, et al. (2013) Serum glycome profiling: a biomarker for diagnosis of ovarian cancer. J Proteome Res. 12:4056-63.
35. Miwa HE, Koba WR, Fine EJ, Giricz O, Kenny PA, Stanley P (2013) Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer. Glycobiology.23:1477-90.
36. Chen Z, Gu J (2007) Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB J. 21:2931-2938. (Pubitemid 47372759)
37. Zhu X, Li C, Sun X, Mao Y, Li G, Liu X, et al. (2008) Immunoglobulin mRNA and protein expression in human oral epithelial tumor cells. Appl Immunohistochem Mol Morphol. 16:232-8. (Pubitemid 351589554)
38. Qiu X, Zhu X, Zhang L, Mao Y, Zhang J, Hao P, et al. (2003) Human epithelial cancers secrete immunoglobulin g with unidentified specificity to promote growth and survival of tumor cells. Cancer Res. 63:6488-95. (Pubitemid 37255201)
39. Kobayashi Y, Tateno H, Dohra H, Moriwaki K, Miyoshi E, et al. (2012) A novel core fucose-specific lectin from the mushroom Pholiota squarrosa. J Biol Chem 5:33973-82.